Navigation Links
Medtronic Sprint Fidelis Defibrillator Lead Lawsuit Claims Center Opens to Aid Victims
Date:10/24/2007

Parker Waichman Alonso LLP Announces Opening of Dedicated Claims Center To Evaluate Numerous Possible Lawsuits Related to Defective Sprint Fidelis

Leads Used With Medtronic Implantable Defibrillators

NEW YORK, Oct. 24 /PRNewswire/ -- The defective Medtronic Sprint Fidelis Defibrillator Leads were implanted into hundreds of thousands of people, leaving all of them at risk for serious injury if a Sprint Fidelis Lead fractures. As a result of this, Parker Waichman Alonso LLP has opened a dedicated Claims Center within their office to review the potential lawsuits of people who were implanted with defective Sprint Fidelis Leads used with Medtronic defibrillators. Medtronic suspended sales and recalled all unused Sprint Fidelis Leads on October 15, 2007 after receiving reports of at least 5 fatalities linked to lead fractures. Parker Waichman Alonso LLP recently filed a lawsuit on behalf of a man who had to undergo a dangerous and life- threatening surgical procedure after a Sprint Fidelis Lead fractured. Parker Waichman Alonso LLP is seeking class action status for this lawsuit to represent all persons in the United States who were implanted with defective leads manufactured by Medtronic, Inc.

If you or a loved one received a Sprint Fidelis Lead with a Medtronic implantable defibrillator, please contact our claims center by visiting http://www.yourlawyer.com. Free case evaluations are also available by calling 1-800-LAW-INFO (1-800-529-4636).

The Sprint Fidelis Lead is a wire that is used to attach a Medtronic implantable defibrillator to the heart. The Sprint Fidelis Lead was first introduced by Medtronic in 2004, and has been used with most of the company's implantable defibrillators since then. This component is used in cardiac defibrillators -- or complex devices with defibrillation capacity -- and not in conventional pacemakers. Some patients with congestive heart failure use devices that include this defibrillation ability, and those are among the machines that use the Sprint Fidelis Lead.

Medtronic's Sprint Fidelis Leads have been shown to have a continuing fracture problem. This defect can cause the defibrillators to deliver a massive and painful electrical shock, or it can cause the device to fail to administer a lifesaving shock when necessary. Such defects were discussed in an article written by doctors at The Minneapolis Heart Institute, one of the premier heart institutes in the world. The researchers at the Minneapolis Heart Institute compared data regarding lead failures in both the Sprint Fidelis models and Medtronic's earlier Sprint Quattro models. The study found the thinner Sprint Fidelis Lead had a higher chance of fracturing than the Sprint Quattro. According to Medtronic's own estimate, approximately 2.3%, or 4,000 to 5,000 people with a Sprint Fidelis Lead will experience fracture within 30 months of having a defibrillator implanted.

When a Sprint Fidelis Lead fractures, a patient must undergo a surgical procedure that can tear and scar the heart tissue and veins through which the Sprint Fidelis Lead wire runs. The surgery to replace a defibrillator lead wire is far riskier than having the device itself replaced.

About Parker Waichman Alonso LLP:

Parker Waichman Alonso LLP is a leading products liability and personal injury law firm that represents plaintiffs nationwide. The firm has offices in New York and New Jersey. Parker Waichman Alonso LLP has assisted thousands of clients in receiving fair compensation for injuries resulting from defective products, drugs and medical devices.

For more information on Parker Waichman Alonso LLP, please visit: http://www.yourlawyer.com or call 1-800-LAW-INFO (1-800-529-4636).

CONTACT: Parker Waichman Alonso LLP

David Krangle, Esq.

(800) LAW-INFO

(800) 529-4636

info@yourlawyer.com

http://www.yourlawyer.com


'/>"/>
SOURCE Parker Waichman Alonso LLP
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Medtronic’s Insulin Pump Receives Regulatory Approva
2. Medtronic Device Proves Effective in Parkinson’s Diseas
3. Short Sprint to Aid in Blood Sugar Recovery among Type 1 Diabetes
4. Defibrillators In Public Places Will Help Cardiac Patients
5. Need to use defibrillators
6. Defibrillators saving lives but price is an issue
7. Public Defibrillators Found To Improve Survival Rate
8. Guidant sold defective defibrillators with full knowledge
9. Combination therapy for patients treated with Implantable Cardioverter Defibrillator
10. New Implantable Cardioverter Defibrillators to avoid unnecessary shocks
11. New Test Identifies Candidates For Cardiac Defibrillator
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... Much attention has been paid to the problem ... on opioid painkillers has fallen short. From 1999 until 2010, fatal overdoses from prescription ... fatal overdoses in male populations.(1) , The proportion of women using illicit drugs is ...
(Date:2/27/2017)... ... 27, 2017 , ... This webinar , sponsored by ... tool to characterize particle size distributions in the field of geoscience and soil ... scientific findings. It describes methods of optimized and standardized sample collection, preparation and ...
(Date:2/27/2017)... ... February 27, 2017 , ... Sunshine Coast Health Centre ... Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition of ... showcases the Centre's commitment to innovation in drug rehab and alcohol treatment strategies ...
(Date:2/26/2017)... MICHIGAN (PRWEB) , ... February 25, 2017 , ... The ... Kim Jong-un, heightened awareness and concern over nerve agents and the deadly use of ... the human nervous system and how even small doses can be lethal. , Jay ...
(Date:2/26/2017)... New York (PRWEB) , ... February 26, 2017 ... ... baby products for wholesale distribution in North America, today announced it would be ... sites. The company, which prides itself on crafting quality and unique baby clothing/feeding ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... Israel , Feb. 27, 2017 ... of adult stem cell technologies for neurodegenerative diseases, announced ... M.D., Ph.D., FACP, and Arturo O. Araya , ... "Dr. Almenoff and Mr. Araya are talented and ... time for our company," said Chaim Lebovits , ...
(Date:2/24/2017)... NEW YORK , February 24, 2017 Following ... Israel , s ... $ 250 M w ound care ... file s BST for inclusion in ... national healthcare reimbursement system   E-QURE Corp. ...
(Date:2/24/2017)... -- Research and Markets has announced the addition of the ... their offering. ... research Hemophilia Drugs Price Analysis and Strategies - 2016, provides drug pricing ... the following questions: What are the key ... in the Global Hemophilia market? What are the unit ...
Breaking Medicine Technology: